The integration of pre-screening all patients for eligibility in oncology studies.
Debra Wujcik, PhD, RN, FAAN
Advertisement
Articles by Debra Wujcik, PhD, RN, FAAN
Physician participation in and patient access to cancer treatment clinical trials (CCTs) are key measures for delivery of quality cancer care.
Advertisement
Latest Updated Articles
Making a Difference in Cancer Trials AccrualPublished: April 1st 2014 | Updated:
Making a Difference in Clinical Trials Accrual: The Integration of Prescreening All Patients for EligibilityPublished: November 8th 2013 | Updated:
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Eli Lilly’s Phase II Trial of Eloralintide Shows Up to 20% Weight Reduction in Adults With Obesity
2
Novo Nordisk’s Phase III OASIS 4 Analyses Highlight Cardiometabolic Benefits of Oral Semaglutide 25 mg
3
FDA Approves UCB’s Kygevi for TK2 Deficiency Based on Multi-Study Clinical Program Demonstrating Significant Survival and Motor Gains
4
Designing Feasible Protocols with Real-World Data
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
